Gene expression profiles in Finnish twins with multiple sclerosis

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Särkijärvi, Silja ^a   Kuusisto, Hanna ^a   Paalavuo, Raija ^a   Levula, Mari ^a,d   Airla, Nina ^a,d   Lehtimäki, Terho ^a,d   Kaprio, Jaakko ^b,c   Koskenvou, Markku ^b   Elovaara, Irina ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; COMPLEMENTARY DNA; HEMOGLOBIN A2; HEMOGLOBIN BETA CHAIN; MEMBRANE PROTEIN; MYXOVIRUS RESISTANCE PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR POU;

ADULT; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; FINLAND; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE TECHNOLOGY; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MONONUCLEAR CELL; MONOZYGOTIC TWINS; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POPULATION GENETICS; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIBLING; TWIN DISCORDANCE; UPREGULATION; GENETICS; METABOLISM; TWINS;

ORTHOMYXOVIRIDAE;

DISEASES IN TWINS; FINLAND; GENE EXPRESSION PROFILING; HUMANS; MULTIPLE SCLEROSIS; TWINS, MONOZYGOTIC; UP-REGULATION;

EID: 33645467086     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-11     Document Type: Article

References (41)

1. Sumelahti ML, Tienari PJ, Wikstrom J, Palo J, Hakama M: Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand 2001, 103:153-158.
2. Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, Murray TJ, Seland TP, Duquette P, Grey T: A population-based study of multiple sclerosis in twins. N Engl J Med 1986, 315:1638-1642.
3. Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA: The British Isles survey of multiple sclerosis in twins. Neurology 1994, 44:11-15.
4. Sadovnick AD, Armstrong H, Rice GP, Bulman D, Hashimoto L, Paty DW, Hashimoto SA, Warren S, Hader W, Murray TJ, Seland TP, Metz L, Bell R, Duquette P, Gray T, Nelson R, Weinshenkar B, Brunt D, Ebers GC: A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993, 33:281-285.
5. Kinnunen E, Juntunen J, Ketonen L, Koskimies S, Konttinen YT, Salmi T, Koskenvuo M, Kaprio J: Genetic susceptibility to multiple sclerosis. A co-twin study of a nationwide series. Arch Neurol 1988, 45:1108-1111.
6. Rasmussen HB, Kelly MA, Clausen J: Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis. Mult Scler 2001, 7:91-93.
7. Bonetti A, Reunanen K, Finnila S, Koivisto K, Wikstrom J, Sumelahti ML, Pirttila T, Elovaara I, Reunanen M, Saarela J, Peltonen L, Rantamaki T, Tienari PJ: A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes Immun 2004, 5:142-146.
8. Jalonen TO, Pulkkinen K, Ukkonen M, Saarela M, Elovaara I: Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes. J Neurol 2002, 249:576-583.
9. Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimaki T: The combination of HLA-DR1 and HLA-DR53 protects against MS. Neurology 2001, 56:383-385.
10. Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimaki T: Plasminogen activator inhibitor 1 gene and risk of MS in women. Neurology 2000, 54:1862-1864.
11. Luomala M, Lehtimaki T, Elovaara I, Wang X, Ukkonen M, Mattila K, Laippala P, Koivula T, Hurme M: A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis. J Neurol Sci 2001, 185:123-127.
12. Luomala M, Lehtimaki T, Huhtala H, Ukkonen M, Koivula T, Hurme M, Elovaara I: Promoter polymorphism of IL-10 and severity of multiple sclerosis. Acta Neurol Scand 2003, 108:396-400.
13. Mattila KM, Luomala M, Lehtimaki T, Laippala P, Koivula T, Elovaara I: Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women. Neurology 2001, 56:1246-1247.
14. Nejentsev S, Laaksonen M, Tienari PJ, Fernandez O, Cordell H, Ruutiainen J, Wikstrom J, Pastinen T, Kuokkanen S, Hillert J, Ilonen J: Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. Hum Immunol 2003, 64:345-349.
15. Pihlaja H, Rantamaki T, Wikstrom J, Sumelahti ML, Laaksonen M, Ilonen J, Ruutiainen J, Pirttila T, Elovaara I, Reunanen M, Kuokkanen S, Peltonen L, Koivisto K, Tienari PJ: Linkage disequilibrium between the MBP tetranucleotide repeat and multiple sclerosis is restricted to a geographically defined subpopulation in Finland. Genes Immun 2003, 4:138-146.
16. Grekova MC, Robinson ED, Faerber MA, Katz P, McFarland HF, Richert JR: Deficient expression in multiple sclerosis of the inhibitory transcription factor Sp3 in mononuclear blood cells. Ann Neurol 1996, 40:108-12.
17. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231.
18. Chen Y, Dougherty ER, Bittner ML: Ratio-Based Decisions and the Quantitative Analysis of cDNA Microarray Images. Journal of Biomedical Optics 1997, 2:364-374.
19. Claverie JM: Computational methods for the identification of differentialand coordinated gene expression. Hum Mol Genet 1999, 8:1821-1832.
20. Kaprio J, Koskenvuo M: Genetic and environmental factors in complex diseases: the older Finnish Twin Cohort. Twin Research 2002, 5:358-365.
21. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR: Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 1984, 38:745-755.
22. Hibbert L, Foster GR: Human type I interferons differ greatly in their effects on the proliferation of primary B cells. J Interferon Cytokine Res 1999, 19:309-318.
23. Kelly JM, Porter AC, Chernajovsky Y, Gilbert CS, Stark GR, Kerr IM: Characterization of a human gene inducible by alpha- and beta-interferons and its expression in mouse cells. Embo J 1986, 5:1601-1606.
24. Clauss IM, Wathelet MG, Szpirer J, Content J, Islam MQ, Levan G, Szpirer C, Huez GA: Chromosomal localization of two human genes inducible by interferons, double-stranded RNA, and viruses. Cytogenet Cell Genet 1990, 53:166-168.
25. Wathelet MG, Clauss IM, Paillard FC, Huez GA: 2-Aminopurine selectively blocks the transcriptional activation of cellular genes by virus, double-stranded RNA and interferons in human cells. Eur J Biochem 1989, 184:503-509.
26. Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C: Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 2003, 37:1180-1188.
27. Chernajovsky Y, Reid TR: Regulation of the human interferon-inducible 6-16 promoter in tumor necrosis factor-sensitive and resistant mouse cells: role of cAMP as a mediator of signal transduction. J Interferon Res 1990, 10:627-636.
28. Herberts CA, van Gaans-van den Brink J, van der Heeft E, van Wijk M, Hoekman J, Jaye A, Poelen MC, Boog CJ, Roholl PJ, Whittle H, de Jong AP, van Els CC: Autoreactivity against induced or upregulated abundant self-peptides in HLA-A*0201 following measles virus infection. Hum Immunol 2003, 64:44-55.
29. Liebert UG, ter Meulen V: Synergistic interaction between measles virus infection and myelin basic protein peptide-specific T cells in the induction of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1993, 46:217-223.
30. Link H, Sun JB, Wang Z, Xu Z, Love A, Fredrikson S, Olsson T: Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1992, 38:63-73.
31. Ohara Y: Multiple sclerosis and measles virus. Jpn J Infect Dis 1999, 52:198-200.
32. Sim FJ, Zhao C, Li WW, Lakatos A, Franklin RJ: Expression of the POU-domain transcription factors SCIP/Oct-6 and Brn-2 is associated with Schwann cell but not oligodendrocyte remyelination of the CNS. Mol Cell Neurosci 2002, 20:669-682.
33. Wegner M, Drolet DW, Rosenfeld MG: Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 1993, 90:4743-4747.
34. Simon A, Fah J, Haller O, Staeheli P: Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J Virol 1991, 65:968-971.
35. Staeheli P: Interferon-induced proteins and the antiviral state. Adv Virus Res 1990, 38:147-200.
36. Haller O, Frese M, Kochs G: Mx proteins: mediators of innate resistance to RNA viruses. Rev Sci Tech 1998, 17:220-230.
37. Haller O, Kochs G: Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 2002, 3:710-717.
38. Bertolotto A, Gilli F, Sala A, Audano L, Castello A, Magliola U, Melis F, Giordana MT: Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification. J Immunol Methods 2001, 256:141-152.
39. Adra CN, Zhu S, Ko J-L, Guillemot J-C, Cuervo AM, Kobayashi H, Horiuchi T, Lelias J-M, Rowley JD, Lim B: LAPTM5: A Novel Lysosomal-Associated Multispanning Membrane Protein Preferentially Expressed in Hematopoietic Cells. Genomics 1996, 35:328-337.
40. Seimiya M, O-Wang J, Bahar R, Kawamura K, Wang Y, Saisho H, Tagawa M: Stage-specific expression of Clast6/E3/LAPTM5 during B cell differentiation: elevated expression in human B lymphomas. Int J Oncol 2003, 22:301-304.
41. Connor JR, Menzies SL: Relationship of iron to oligodendrocytes and myelination. Glia 1996, 17:83-93.